Search bioRxiv⌕ Search

Biology subjects

P, S. S.

Publications and source records attributed to P, S. S..

2 recordsLinked to original sources

Structure-aware graph attention based hierarchical transformer framework for drug-target binding affinity prediction

Drug-target interaction prediction is significant in the hit identification phase of drug discovery, enabling the identification of potential drug candidates for downstream optimization. Traditional computational methods have some drawbacks in their ability to represent 3D structural data for both molecules and target proteins, which is required for the intricate protein-ligand interactions that regulate binding affinity. In this approach, we propose a graph transformer-based model (GTStrDTI) that combines an intragraph attention mechanism with cross-modal attention to enrich the representation of both the drug molecule and target protein. This approach comprehensively models both intramolecular structural features and intermolecular interactions, thereby enhancing binding affinity prediction performance. A thorough evaluation on benchmark datasets such as KIBA, DAVIS, and BindingDB_Kd shows that our approach surpasses the state-of-the-art methods under challenging target cold-start settings. Our analysis found that augmenting graph-based 3D structural protein target (C-alpha contact graphs from PDB with threshold distance of 5[A]) and incorporating molecule adjacency information, boosts predictive performance, thus contributing towards narrowing the gap between computational and experimental research.

bioinformatics↗

Sequence-Driven Drug-Target Affinity Prediction Via Graph Attention Networks and Bidirectional Cross-Attention Fusion

Accurate prediction of drug-target affinity (DTA) is a core challenge in computational drug discovery. Structure-based methods depend on experimentally determined protein coordinates, which are unavailable for most drug-relevant targets. sequence-only approaches, in turn, operate on linear residue representations and lack an explicit mechanism to encode the spatial proximity relationships that govern protein-ligand interactions. We present XAttn-DTA, a sequence-driven framework that addresses both limitations without requiring experimental structural data. Drug molecules are encoded as 2D molecular graphs via multilayer Graph Attention Networks (GATs), capturing atomic topology and bond-level chemistry. Proteins are represented as residue-level graphs constructed from ESM2-predicted contact maps, that captures inter-residue coevolutionary and structural signals embedded within the sequence. The bidirectional cross-attention fusion module projects both embeddings into a shared latent space and applies dual multi-head cross-attention. This enables ligand and protein residue environments to inform one another. On the Davis benchmark, XAttn-DTA achieves a concordance index (CI) of 0.907 and MSE of 0.175, improving CI by 1.8% and reducing MSE by 9.3% over the strongest baseline. On KIBA, it achieves an MSE of 0.121, a 13.6% reduction. Under three strict cold-start settings across Davis, KIBA, and BindingDB, the model yields MSE reductions of up to 79.0% and CI improvements of up to 31.5% over the strongest baseline, demonstrating strong generalization to unseen scaffolds and novel protein families.

bioinformatics↗